Nutrient quality
Named small-fish sources and a balanced active profile provide a sound basic formula. The moderate dose and missing molecular-form, antioxidant, and testing details limit depth.
.| $ 71.00 | ||
Vitacost | $ 71.00 |
The formula supplies 300 mg EPA and 200 mg DHA per serving, giving a moderate omega-3 dose. Both key omega-3s are quantified, so the active amount is easy to assess.
The serving fits people who want a moderate daily omega-3 amount for cardiovascular support and anti-inflammatory support. The active-dose value is reasonable, though alternatives may provide more omega-3 per serving.
The label does not identify the omega-3 molecular form or provide independent purity and oxidation test results, so important quality details remain uncertain. The capsule(s) format may be convenient for routine use, but the disclosed facts do not establish freshness or contaminant control.
Named small-fish sources and a balanced active profile provide a sound basic formula. The moderate dose and missing molecular-form, antioxidant, and testing details limit depth.
.Active amounts are individually disclosed, and no proprietary blend hides the supplied doses. Complete use directions, excipients, and some source or quality details remain unavailable.
.Supplied aggregate data indicate very strong satisfaction with a limited response base. Specific comments are absent, so recurring complaints and purpose-specific experiences cannot be verified.
.Named sourcing and a simple formula provide fair value. A modest active dose and limited quality documentation weaken competitiveness.
.Clearly quantified EPA and DHA provide direct, evidence-backed support for healthy inflammatory signaling. The dose is useful but lower than amounts often used for more intensive inflammation goals.
It offers strong depth on the omega-3 pathway without unnecessary extras. People using anticoagulant or antiplatelet therapy should consider the added blood-thinning effect of fish oil.
The formula directly supports cardiovascular health with separately disclosed EPA and DHA from named small-fish sources. These omega-3 fats have strong evidence for lipid support, but the combined amount is modest for a targeted triglyceride effect.
The focused softgel is coherent and easy to assess, with no low-dose heart-health extras. Missing molecular-form, purification, independent-testing, and antioxidant-stabilizer details limit confidence in quality and oxidation control.
DHA supports retinal membrane structure, while EPA may contribute to ocular surface and inflammatory balance. The combination is relevant to vision but does not provide macular pigments or the antioxidant nutrients used in established eye formulas.
The 200 mg DHA and 300 mg EPA amounts provide a moderate contribution, with exact fatty-acid quantities clearly listed. Molecular form, oxidation protection, and independent contaminant testing are not disclosed.
| Ingredient | Amount per serving |
|---|---|
Calories | 10 Calorie(s) |
Total Fat | 1 Gram(s) |
Cholesterol | 5 mg |
Fish Oil concentrate | 1000 mg |
Eicosapentaenoic Acid | 300 mg |
Docosahexaenoic Acid | 200 mg |
The formula provides a moderate 300 mg EPA dose with a favorable EPA-to-DHA ratio. Its molecular form, antioxidant protection, and contaminant testing are not disclosed. Cost efficiency is average for the amount of EPA delivered.
The formula clearly provides separate EPA and DHA amounts, but their combined dose is modest. Its concentration is standard, while the named small-fish sources support ingredient origin. Molecular form, purification, independent testing, and antioxidant protection are not stated, and active cost is only average.
Anchovy, mackerel, and sardine provide a transparent small-fish source with balanced EPA and DHA. The DHA serving remains low, and neither chemical form nor antioxidant protection is disclosed. The long supply does not overcome relatively high cost per active DHA and missing purity verification.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.